Proteomics aid in defining salivary biomarkers
Recent advances in mass spectrometric proteomics provide a promising result in utilizing saliva to explore biomarkers for diagnostic purposes, according to researchers from the University
Recent advances in mass spectrometric proteomics provide a promising result in utilizing saliva to explore biomarkers for diagnostic purposes, according to researchers from the University
Health warnings on cigarette packages prompt smokers to think about quitting, according to a 14-nation study. Effective warning labels as a component of comprehensive tobacco
The Terry Fox Research Institute (TFRI) in Vancouver has launched a $4.7 million Pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral
Indian wild plants may play a role in fighting bacterial and fungal infections in the mouths of oral cancer patients, according to new research (Annals
A retrospective study in Head and Neck Oncology (May 21, 2011) provides new treatment strategies for primary tumor disease and tumor recurrence in patients with
Mydent International, manufacturer for Defend and private-label disposables, preventatives, infection control products, and impression material systems, is offering free samples of its Defend products to
A primary reason that head and neck cancer treatments fail is that the tumor cells become resistant to chemotherapy drugs. Now researchers at the University
Cigarette manufacturers have deceived consumers about the risks of their products for years, and remedial actions are needed so consumers can make informed decisions about
Dwight Pemberton, DDS, the dentist at the Veterans’ Affairs (VA) Medical Center in Dayton, OH, whose lax infection control practices potentially exposed hundreds of patients
HuangshanDental.com is pleased to present a new feature series, Leaders in Dentistry, a series of interviews with researchers, practitioners, and opinion leaders who are influencing
Econo-Keys has partnered with WetKeys to offer Econo-Keys’ products at a significant discount to dental offices, hospitals, manufacturing facilities, and other areas where infection control
Sosei has acquired development and commercialization rights to Loramyc in Japan from BioAlliance Pharma. Loramyc is an antifungal agent administered as a mucoadhesive buccal tablet